Plain-English translation of NCT06011499 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial tests a program called iLIVE that combines online weight loss support with group-based strength training exercises, delivered entirely over the internet. The study is designed for prostate cancer survivors who are overweight or obese and experiencing frailty — meaning they feel weak, tired, or less active than they used to. Researchers want to see if this program can help you regain strength, lose weight, and improve your overall quality of life.
Prostate cancer survivors, especially those receiving certain hormone treatments, often struggle with weight gain and weakness that makes everyday activities harder. This trial exists to test whether an accessible, online program can help reverse these effects and give survivors better tools to feel strong and healthy again.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either the full iLIVE program or a usual care group. If you're in the iLIVE group, you'll access an interactive website for weight loss guidance and join online group strength-training sessions. Both groups will receive a Fitbit fitness tracker and a smart scale to monitor your progress. You'll participate for several months, then be followed for 6 additional months after the program ends to see how well the changes stick. Some participants may also be asked to participate in interviews to share their feedback about the program.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
United States